Trial intelligence / Profile preview

Remimazolam vs midazolam sedation for fiberoptic bronchoscopy in elderly patients

ChiCTR2100047459Phase 4Recruiting

Sponsor
Hangzhou First People's Hospital
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoints: Time to drug onset, Opioid use dose and 3 more. Started Jul 2021; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2100047459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call